Track MEDNAX, Inc. — Monitor price, dividends, and performance in your free portfolio

Start Tracking Free

MEDNAX, Inc. MD · Stock Open MEDNAX, Inc. in new tab

26.25 USD
P/E
12.87
EPS
2.06
P/B
2.42
ROE
20.89
Beta
0.66
Target Price
24.50 USD
Loading chart...
Key Metrics
Earnings dateAug. 4, 2026
P/E12.87
EPS2.06
Book Value10.97
Price to Book2.42
Debt/Equity71.68
% Insiders2.006%
Growth
Revenue Growth0.04%
Earnings Growth0.50%
Estimates
Forward P/E11.24
Forward EPS2.36
Target Mean Price24.50

DCF Valuation

Tweak assumptions to recompute fair value for MEDNAX, Inc. (MD)
Currency: USD
DCF Assumptions
Decimal (e.g., 0.10 = 10%). Range allows declines (−50%) to strong growth (+50%).
Decimal (e.g., 0.30 = 30%).
Decimal (e.g., 0.04 = 4%).
Decimal (e.g., 0.20 = 20%).
Percent number (e.g., 3 = 3%).
Percent number (e.g., 10 = 10%).
Percent number (e.g., 5 = 5%).
DCF Result

Fair Value (DCF)
Current Price
Upside
WACC
Terminal PV
Σ PV of FCFs
Note: historical bars show reported FCF (for context); forward bars show PV of projected FCF; if no per-year data, totals are shown.

MEDNAX, Inc. Logo MEDNAX, Inc. Analysis (MD)

United States Health Care Official Website Stock

Is MEDNAX, Inc. a good investment? MEDNAX, Inc. (MD) is currently trading at 26.25 USD. Market analysts have a consensus price target of 24.50 USD. This suggests the asset is currently trading above analyst expectations.

In terms of valuation, the stock trades at a P/E ratio of 12.87. This relatively low multiple may signal that MEDNAX, Inc. is undervalued compared to historical market norms.

Earnings Schedule: MEDNAX, Inc. is expected to release its next earnings report on Aug. 4, 2026. The market consensus estimate for Forward EPS is 2.36.

Investor FAQ

Does MEDNAX, Inc. pay a dividend?

No, it does not currently pay a dividend.

What asset class is MEDNAX, Inc.?

MEDNAX, Inc. is classified as a Stock. You can compare it against its peer in the "Related Symbols" list.

When is the next earnings date?

The next earnings date is projected to be Aug. 4, 2026. The company currently has a trailing EPS of 2.06.

Company Profile

Pediatrix Medical Group, Inc., together with its subsidiaries, provides newborn, maternal-fetal, and other pediatric subspecialty care services in the United States. The company offers clinical care to babies born prematurely or with complications within specific units at hospitals, primarily NICUs, through its network of affiliated neonatal physician subspecialists, neonatal nurse practitioners, and other pediatric clinicians; and inpatient and office-based clinical care to expectant mothers and unborn babies through its affiliated maternal-fetal medicine subspecialists, obstetricians and other clinicians, maternal-fetal medicine nurse practitioners, certified nurse midwives, sonographers, and genetic counselors. It also provides other pediatric subspecialty care, including pediatric intensivists, pediatric hospitalists, and pediatric surgeons; support services in other areas of hospitals comprising pediatric emergency room, labor and delivery area, and nursery and pediatric departments; a newborn hearing screening program. The company was formerly known as MEDNAX, Inc. and changed its name to Pediatrix Medical Group, Inc. in July 2022. Pediatrix Medical Group, Inc. was founded in 1979 and is based in Sunrise, Florida.

Exchange Ticker
NYQ (United States) MD
Trades
Dividend History paid per year (USD)
No dividend history available.
Stock Splits
Split Date Split Ratio to 1
April 28, 2006 2.000000
Dec. 20, 2013 2.000000
Explore Premium Features

Unlock detailed news and exclusive insights with our Premium subscription.

See Pricing Plans

Fundamentals

Under Construction

This feature will be available soon. Stay tuned!

Follow us on Twitter for updates: @allinvestview

Check out our Roadmap for upcoming features.

Community Discussion